Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May 28:9:648020.
doi: 10.3389/fcell.2021.648020. eCollection 2021.

Commentary: In vivo Neuroregeneration to Treat Ischemic Stroke Through NeuroD1 AAV-Based Gene Therapy in Adult Non-human Primates

Xiaoqin Zhang  1 , Fenghua Chen  1 , Youcui Wang  1
Affiliations
Comment

Commentary: In vivo Neuroregeneration to Treat Ischemic Stroke Through NeuroD1 AAV-Based Gene Therapy in Adult Non-human Primates

Xiaoqin Zhang et al. Front Cell Dev Biol. .
No abstract available

Keywords: NeuroD1; astrocyte-to-neuron; in vivo; non-human primates; stroke.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Arenas E. (2020). Method to combat Parkinson's disease by astrocyte-to-neuron conversion. Nature 582, 489–490. 10.1038/d41586-020-01817-4 - DOI - PubMed
    1. Brulet R., Matsuda T., Zhang L., Miranda C., Giacca M., Kaspar B. K., et al. . (2017). NEUROD1 instructs neuronal conversion in non-reactive astrocytes. Stem Cell Rep. 8, 1506–1515. 10.1016/j.stemcr.2017.04.013 - DOI - PMC - PubMed
    1. Chen W., Huang Q., Ma S., Li M. (2019). Progress in dopaminergic cell replacement and regenerative strategies for Parkinson's disease. ACS Chem. Neurosci. 10, 839–851. 10.1021/acschemneuro.8b00389 - DOI - PubMed
    1. Chen Y. C., Ma N. X., Pei Z. F., Wu Z., Do-Monte F. H., Keefe S., et al. . (2020). A NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion. Mol. Ther. 28, 217–234. 10.1016/j.ymthe.2019.09.003 - DOI - PMC - PubMed
    1. Cook D. J., Nguyen C., Chun H. N. L., Llorente I., Chiu A. S., Machnicki M., et al. . (2017). Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke. J. Cereb. Blood Flow Metab. 37, 1030–1045. 10.1177/0271678X16649964 - DOI - PMC - PubMed

LinkOut - more resources